|
|
Profile
|
Delegates :
Henry Aoki |
|
Incorporated :
April 8 , 2003 |
Paid in Capital :
10 Million yen |
Employees :
3 人 |
Address :
6 Ledge Rock Way, Unit 9, Acton, MA USA TOKYO
〒01720-6535
|
TEL/FAX :
978-742-9830 / 978-742-9830 |
URL：
http://www.ygsrs.com |
Attachment :
|
Mission/Background :
Henry Aoki is an engineer with long technical development background. Using the technology he developed, extraction and solidification process, to restore health and maintain health of human being is our mission. We strive to create multiple nature based bioactive substances one after another, and we aim to extend its use in wide range of field. |
|
Technology & Business
|
The technology, extraction and solidification process, is able to extract from various food material only the bioactive ingredient that was not possible to extract previously and make a solid form. That solidified bioactive ingredient is identified, and there will be discovery of new substance that is highly bioactive with anti-cancer, anti-inflammatory property. In pharmaceutical development, it has been long said that extraction, separation, and purification of bioactive ingredient is very difficult and time consuming. This technology is able to achieve that goal with ease in short time and low cost. It will be tremendous streamlining.To build up pipeline of many new pharmaceutical candidate is possible.
Peptide that will be discovered using this technology will have short sequence and high safety
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
YGSRS peptide discovered from coffee beans
|
Preclinical
|
Anti-cancer, anti-inflammatory activity, low toxicity, patented. Scientific paper published.
|
License out as pharmaceutical candidate, functional food material.
|
BD-203 New substance from food material
|
Discovery
|
Prospect of discovery of substance with anti-cancer, anti-inflammatory activity as drug candidate
|
Invite collaborative research, partnership
|
BD-305 New substance from a food material
|
Discovery
|
Prospect of discovery of substance with anti-cancer, anti-inflammatory activity as drug candidate
|
Invite collaborative research, partnership
|
|
|
|
|
|
|
|
|
|
Highlights
|
YGSRS peptide was discovered from coffee beans and patented. Highly bioactive. At 10mcg/kg wt., it exhibited 100% inhibition rate in Sarcoma and Inflammation. Scientific paper has been published in "Immunopharmacology and Immunotoxicology" in Great Britain.
Xanthone Derivative was discovered from mung bean and patented. Highly bioactive. At 10mcg/kg wt., it exhibited 100% inhibition rate in Sarcoma and Inflammation.
|
|
Alliance strategy
|
Invite companies for collaborative research or partnership in discovering new drug candidate (new peptide with short sequence and other pharmaceutical candidate) from various food material using our technology.
|
|
|